Abstract
Enterotoxaemia caused by Clostridium perfringens type D (pulpy kidney disease) is a common disease of sheep and goats.Commercial sheep enterotoxaemia vaccines consist of an epsilon toxoid adsorbed onto an adjuvant (usually aluminium hydroxide), and because no enterotoxaemia vaccines are specially manufactured for goats, these sheep vaccines are also generally used in that species. There are abundant references about immunity to enterotoxaemia in sheep and there is no doubt that sheep can be fully protected against this disease by vaccination. However, data on antibody titres and local reactions in goats after enterotoxaemia vaccination are scanty and contradictory. We present here a vaccination trial with a commercial vaccine in goats in order to measure their antibody responses and local reactions to different vaccination regimes.© 1999 Academic Press
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
